Back

Accelerometer-derived circadian rhythm parameters are associated with risk of malignant ventricular arrhythmias in implantable cardioverter defibrillator patients

21 November 2025 (08:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Smart health, smarter care: leveraging wearables for monitoring Wearables Open Access ESC Digital & AI Summit 2025 European Society of Cardiology

About the speaker

Photo
Mrs Femke Raijmakers

Amsterdam University Medical Centre (AUMC), Amsterdam (Netherlands (The))

5 More presentations in this session

Presentation thumbnail
National trends in the use of wearables for health management and sharing of data with clinicians in the United States, 2020-2024
Doctor R. Khera (New Haven, US)
Abstract Slides
Presentation thumbnail
Evaluation of a wearable medical device for ambulatory screening of obstructive sleep apnea in atrial fibrillation patients after ablation.
Doctor J. Benezet Mazuecos (Madrid, ES)
Abstract Slides
Presentation thumbnail
Ring-type PPG sensor for the detection of ventricular arrhythmias
Ms N. Van Steijn (Amsterdam, NL)
Abstract Slides
Presentation thumbnail
Accuracy and reproducibility of accelerometer-assessed walking distance in heart failure patients using Mobilise-D algorithms
Mr H. Sillen (Gothenburg, SE)
Abstract Slides
Presentation thumbnail
Photoplethysmography-derived features associated with left ventricular dysfunction: explanatory analysis from an observational study
Mr M. Basza (Warsaw, PL)
Abstract Slides

Access the full session

Session thumbnail
Smart health, smarter care: leveraging wearables for monitoring

The Event

Event poster

ESC Digital & AI Summit 2025

21 November - 22 November 2025
You may be interested in
thumbnail
Congress Presentation
Real-world evaluation of an algorithmic machine-learning-guided testing approach in stable chest pain: a multinational, multicohort study
thumbnail
Congress Presentation
Wearable technologies and digital biomarkers: validity and usability
thumbnail
Congress Presentation
Digital health technologies and artificial intelligence in secondary prevention improving health equity - discussion

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources